Description
Tranexamic Acid Injection (500 mg) is a synthetic derivative of the amino acid lysine, which is an antifibrinolytic agent which is designed to manage and prevent excessive blood loss and critical clinical scenarios. It works as a competitive inhibitor of plasminogen activation, which prevents the premature breakdown of fibrin clots, the meshwork that stops bleeding. This injectable solution serves as a vital intervention in both surgical and emergency medicine that binds to plasminogen, which pauses the “clot-dissolving: mechanism of the body and allows the wound or surgical site to remain stable. It ensures rapid action and systemic reliability when patients need it most and makes it indispensable for acute blood management.
Medical Uses
The Tranexamic Acid Injection has broad clinical applications, which include:
- It is used during the critical process of surgical Hemostasis, including major orthopedic, cardiac, and gynecological surgeries, to reduce blood loss.
- Tranexamic Acid Injection is effective in serious conditions, such as during trauma care from physical injury or accidents.
- The injectable is used in Postpartum Hemorrhage (PPH) to control severe bleeding after childbirth.
- It can be used to treat refractory nosebleeds or heavy menstrual flow when oral therapy is insufficient.
- The injectable is specifically used during Dental extraction in patients with hemophilia to prevent post-procedural bleeding.
Directions to Use
- The Tranexamic acid injection is intended for Intravenous (IV) use only, and it must be administered by a healthcare professional via slow injection or infusion.
- The dose would be determined by the healthcare professional based on the patient’s body weight and the severity of the condition.
- Follow the prescribed dosage properly and avoid rapid injection (rapid-acting insulin), as it may cause a sudden drop in blood pressure.
Precautions
- It is advised to use cautiously in patients with a history of active thromboembolic disease, such as DVT or pulmonary emboism and it should be used after medical consultation only.
- Since the drug is excreted by the kidneys, it requires dosage adjustment for patients with impaired renal function.
- Do not exceed and skip the prescribed dosage and duration. Always follow the prescription strictly.
- Keep this medication away from children and pets.
- If any visual disturbance happens during the treatment process, then immediately seek medical attention and halt the administration until it is resolved, as advised by the healthcare professionals.
Possible Side Effects
Tranexamic Acid Injection is safe and well-tolerated, though a very few individuals have experienced some common side effects after intervention. These side effects are rare, and they become normal after a few hours.
- Nausea
- Diarrhea
- Dizziness or hypotension 9if injected too rapidly)
- Skin reaction or rashes on a patient with hypersensitive skin.
- Deep vein thrombosis (very rare)
If you are dealing with any one of the symptoms after administration or during the treatment course, then seek medical attention.
Frequently Asked Questions
Q: Can this injection be mixed with blood or penicillins in the same IV line?
A: No. Tranexamic Acid Injection should not be mixed with blood or solutions containing penicillin, as these combinations can lead to chemical incompatibility.
Q: Why is the “slow injection” protocol emphasized so strongly for this specific 500 mg dose?
A: Injecting too quickly can trigger a transient hypotensive crisis, where blood pressure drops sharply. Slow administration ensures the body adjusts to the antifibrinolytic shift.
Q: Does Knox Life Sciences provide this medication for institutional hospital supply or retail only?
A: We primarily cater to hospitals and trauma centers through specialized distribution channels, ensuring this critical care medication is available where emergency surgeries occur.
Q: Is there a specific protocol for using this injection in hereditary angioedema cases?
A: While used off-label, it helps prevent attacks by inhibiting specific enzyme pathways. However, a specialist must tailor the dose to the patient’s frequency.
Q: How long does the clot-stabilizing effect of a single 500 mg dose typically last?
A: The therapeutic effect usually persists in the tissues for about 15–17 hours, providing a significant window of protection during the critical recovery phase.
Q: Are there any specific storage requirements to maintain the clear color of the solution?
A: Store at room temperature and protect from light. If the solution shows any discoloration or particulate matter, the vial must be discarded immediately.
